Inactief instrument

Andere talen First Light Acquisition Group, Inc. Nyse

Aandelen

FLAG.U

US3207032000

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Calidi Biotherapeutics Announces Upcoming Presentations at the 2024 ASCO Annual Meeting	01/05
Join Calidi Biotherapeutics Exclusive Live Investor Webinar and Q&A Session on April 24	24/04
Join Calidi Biotherapeutics’ Exclusive Live Investor Webinar and Q&A Session on April 24	23/04
Calidi Biotherapeutics, Inc. Announces Closing of $6.1 Million Public Offering	19/04
Calidi Biotherapeutics Prices $6.1 Million Offering	16/04
Calidi Biotherapeutics, Inc. Announces Pricing of $6.1 Million Public Offering	16/04
Calidi Biotherapeutics Presents New Data on the Mechanisms of Action for Virotherapy-Loaded Stem Cells Used in the Company's Novel Immunotherapies at the AACR Annual Meeting 2024	10/04
Calidi Biotherapeutics Presents New Data on the Mechanisms of Action for Virotherapy-Loaded Stem Cells Used in the Company’s Novel Immunotherapies at the AACR Annual Meeting 2024	09/04
Calidi Biotherapeutics, Inc. announced that it has received $3.5 million in funding	21/03
Calidi Biotherapeutics Reports Fourth Quarter and Full-Year 2023 Operating and Financial Results	15/03
Calidi Biotherapeutics and City of Hope Announce Funding from the California Institute for Regenerative Medicine (CIRM) to Advance CLD-101 (NeuroNova) in Ovarian Cancer	11/03
Calidi Biotherapeutics, Inc. announced that it expects to receive $3.5 million in funding	08/03
Calidi Biotherapeutics to Highlight Novel Systemic Enveloped Oncolytic Virotherapy Platform Designed to Target All Tumor Sites at Upcoming Conference	12/02
Sector Update: Health Care Stocks Firmer Late Afternoon	07/02
Calidi Biotherapeutics to Sell Common Stock	07/02
Calidi Biotherapeutics, Inc. announced that it has received $1 million in funding	26/01
Calidi Biotherapeutics Announces the Appointment of Three New Members to its Scientific and Medical Advisory Board	08/01
Calidi Biotherapeutics, Inc. Announces Scientific and Medical Advisory Board Appointments	08/01
Calidi Biotherapeutics, Inc.(NYSEAM:CLDI) added to S&P TMI Index	18/12
Calidi Biotherapeutics Announces Appointment of Pharmaceutical Industry Veteran David LaPre to its Board of Directors	13/12

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen First Light Acquisition Group, Inc. Nyse

Aandelen

FLAG.U

US3207032000

Andere talen

Filters